| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |